1. Home
  2. RNA vs KAI Comparison

RNA vs KAI Comparison

Compare RNA & KAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • KAI
  • Stock Information
  • Founded
  • RNA 2012
  • KAI 1991
  • Country
  • RNA United States
  • KAI United States
  • Employees
  • RNA N/A
  • KAI N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • KAI Industrial Machinery/Components
  • Sector
  • RNA Health Care
  • KAI Industrials
  • Exchange
  • RNA Nasdaq
  • KAI Nasdaq
  • Market Cap
  • RNA 3.6B
  • KAI 3.8B
  • IPO Year
  • RNA 2020
  • KAI N/A
  • Fundamental
  • Price
  • RNA $28.39
  • KAI $325.42
  • Analyst Decision
  • RNA Strong Buy
  • KAI Buy
  • Analyst Count
  • RNA 14
  • KAI 2
  • Target Price
  • RNA $68.00
  • KAI $327.50
  • AVG Volume (30 Days)
  • RNA 1.4M
  • KAI 125.7K
  • Earning Date
  • RNA 08-08-2025
  • KAI 07-29-2025
  • Dividend Yield
  • RNA N/A
  • KAI 0.43%
  • EPS Growth
  • RNA N/A
  • KAI N/A
  • EPS
  • RNA N/A
  • KAI 9.42
  • Revenue
  • RNA $8,927,000.00
  • KAI $1,043,619,000.00
  • Revenue This Year
  • RNA N/A
  • KAI N/A
  • Revenue Next Year
  • RNA $156.80
  • KAI $4.52
  • P/E Ratio
  • RNA N/A
  • KAI $33.70
  • Revenue Growth
  • RNA N/A
  • KAI 6.83
  • 52 Week Low
  • RNA $21.51
  • KAI $281.30
  • 52 Week High
  • RNA $56.00
  • KAI $429.95
  • Technical
  • Relative Strength Index (RSI)
  • RNA 38.87
  • KAI 57.47
  • Support Level
  • RNA $28.36
  • KAI $295.98
  • Resistance Level
  • RNA $30.52
  • KAI $312.78
  • Average True Range (ATR)
  • RNA 1.36
  • KAI 8.76
  • MACD
  • RNA -0.36
  • KAI 0.56
  • Stochastic Oscillator
  • RNA 10.40
  • KAI 74.12

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

About KAI Kadant Inc

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.

Share on Social Networks: